DRREDDY Intraday Analysis...
Click Here

DRREDDY Share Price
Open 3253.00 Change Price %
High 3283.00 1 Day -27.15 -0.83
Low 3227.00 1 Week -130.70 -3.86
Close 3252.20 1 Month -97.40 -2.91
Volume 497009 1 Year 419.00 14.79
52 Week High 3666.25
52 Week Low 2246.50
DRREDDY Important Levels
Resistance 2 3304.11
Resistance 1 3282.72
Pivot 3254.07
Support 1 3221.68
Support 2 3200.29
DRREDDY CURRENT MONTH FUTURE
Close 3263.20
Contracts Traded 5488
Open Intrest 192625
Change In O.I -264750
Lot Size 125
DRREDDY CURRENT MONTH OPTION
Most Active Call 3400
Most Active put 3250
Highest O.I Buildup Call 3400
Highest O.I Buildup Put 3100
Expiry Date 26-Feb-2015
DRREDDY ALL MONTHS OPTIONS
For All DRREDDY Options Click Here
NSE INDIA Most Active Stocks
NIFTY 8683.85 -0.95%
UNITECH 18.50 2.49%
L&TFH 66.85 1.21%
INFRATEL 366.50 -1.56%
SUZLON 25.75 -1.15%
CNXIT 12458.50 -1.38%
NTPC 153.35 5.00%
SBIN 289.40 -2.08%
TEXRAIL 135.65 -2.52%
JPPOWER 11.75 -1.67%
More..
NSE INDIA Top Gainers Stocks
BLUECHIP 0.30 20.00%
SUDAR 25.55 14.57%
HIRECT 89.40 13.16%
MVL 0.50 11.11%
MVL 0.50 11.11%
DIGJAM 8.75 10.76%
RAJRAYON 0.55 10.00%
PGEL 109.90 9.52%
A2ZINFRA 19.05 9.48%
WELINV 40.70 9.12%
More..
NSE INDIA Top Losers Stocks
VISESHINFO 0.10 -33.33%
ANTGRAPHIC 0.15 -25.00%
VKSPL 0.20 -20.00%
ATNINTER 0.35 -12.50%
RASOYPR 0.40 -11.11%
ZENITHBIR 0.85 -10.53%
GEMINI 1.35 -10.00%
TODAYS 2.75 -9.84%
RMMIL 1.95 -9.30%
DSSL 10.10 -8.60%
More..

Dr. Reddy s Laboratories Limited (NSE: DRREDDY)

DRREDDY Technical Analysis 3
As on 26th Feb 2015 DRREDDY Share Price closed @ 3252.20 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2926.70 & Buy for SHORT-TERM with Stoploss of 3235.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
DRREDDY Target for February
1st Target up-side 3440.21
2nd Target up-side 3585.28
3rd Target up-side 3730.34
1st Target down-side 3026.29
2nd Target down-side 2881.22
3rd Target down-side 2736.16
Dr. Reddy s Laboratories Limited ( NSE INDIA Symbol : DRREDDY )
Sector : Healthcare And Other Stocks in Same Sector
ZANDUREALT
1669.55 -48.65 (-2.83 %)
LT : Buy
ST : Strong Sell		 VIMTALABS
60.00 -0.05 (-0.08 %)
LT : Strong Sell
ST : Strong Sell		 VHL
715.05 -5.95 (-0.83 %)
LT : Buy
ST : Sell		 VENUSREM
146.45 -5.20 (-3.43 %)
LT : Strong Sell
ST : Strong Sell		 TORNTPHARM
1070.95 -32.20 (-2.92 %)
LT : Buy
ST : Sell
DRREDDY Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
 Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 56.68 Sideways
MFI (14) MFI is 61.15 Sideways
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is -37.36 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 2379.01
10 Day Avg Volume Traded 4.58 % More then 10 Day Average Volume
DRREDDY Other Details
Segment EQ
Market Capital 256400883712.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.drreddys.com
DRREDDY Address
DRREDDY
 Door No. 8-2-337
Road No 3
Hyderabad, 500034
India
Phone: 91 40 4900 2900
Fax: 91 40 4900 2999
DRREDDY Latest News
Dr Reddys Labs - Grant of Stock Options   Moneycontrol.com   - 26th May 14
Dr. Reddy's Laboratories Limited Upgraded by Barclays to "Overweight" (RDY)   Watch List News (press release)   - 24th May 14
Dr. Reddy's Laboratories Limited Dr. Reddy's to release Q4 and Full Year FY14 ...   The Wall Street Transcript   - 22nd May 14
July 19th Options Now Available For Dr. Reddy's Laboratories (RDY)   NASDAQ   - 19th May 14
Dr. Reddy's Laboratories Limited Downgraded by TheStreet to Hold (RDY)   Mideast Time   - 19th May 14
Dr Reddy Laboratories Ltd Stock Downgraded (RDY)   TheStreet.com   - 15th May 14
Bank of America Downgrades Dr. Reddy's Laboratories Limited to Underperform ...   Watch List News (press release)   - 15th May 14
Dr. Reddy's Laboratories Limited Upgraded by Zacks to Buy (RDY)   Zolmax   - 14th May 14
Dr. Reddy's Laboratories Limited (RDY) Releases Quarterly Earnings Results   WKRB News   - 13th May 14
Dublin-based Amarin Pharma files patent case against Dr Reddy's   NDTV   - 04th May 14
Interactive Technical Analysis Chart Dr. Reddy s Laboratories Limited ( DRREDDY NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Dr. Reddy s Laboratories Limited
DRREDDY Business Profile
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 41,432.04 crore.The company has reported a consolidated sales of Rs 3357.45 crore and a Net Profit of Rs 690.25 crore for the quarter ended Sep 2013. The company management includes G V Prasad - Chairman & CEO, Satish Reddy - Vice Chairman & Mng.Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, J P Moreau - Independent Director, Kalpana Morparia - Independent Director, Omkar Goswami - Independent Director, Ravi Bhoothalingam - Independent Director, Sridar Iyengar - Independent Director. It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY. Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills Hyderabad,Andhra Pradesh - 500034. On 24th February 1984 founder Chairman Dr. K Anji Reddy establishes Dr. Reddy's Laboratories with an initial capital outlay of Rs.25 lakhs.